tiprankstipranks
Caladrius Biosciences Inc. (CLBS)
NASDAQ:CLBS

Caladrius Biosciences (CLBS) Financial Statements

0 Followers

Caladrius Biosciences Financial Overview

Caladrius Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Caladrius Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -6.72M$ -6.62M$ -6.85M$ -6.97M$ -7.15M
EBITDA$ -6.71M$ -6.61M$ -6.84M$ -6.95M$ -7.13M
Net Income Common Stockholders$ -6.63M$ -4.23M$ -6.79M$ -6.93M$ -5.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.57M$ 40.27M$ 72.99M$ 88.52M$ 94.97M
Total Assets$ 85.88M$ 91.46M$ 97.01M$ 102.54M$ 108.61M
Total Debt$ 231.00K$ 284.00K$ 384.00K$ 551.00K$ 710.00K
Net Debt$ -34.34M$ -39.98M$ -72.61M$ -87.97M$ -94.26M
Total Liabilities$ 3.74M$ 3.22M$ 5.01M$ 4.13M$ 3.94M
Stockholders Equity$ 32.50M$ 37.74M$ 82.39M$ 88.50M$ 92.25M
Cash Flow-
Free Cash Flow$ -5.30M$ -5.64M$ -4.60M$ -5.04M$ -4.69M
Operating Cash Flow$ -5.06M$ -5.64M$ -4.60M$ -5.04M$ -4.63M
Investing Cash Flow$ 25.63M$ -6.09M$ 16.46M$ 4.94M$ -11.20M
Financing Cash Flow$ 29.00K$ -168.00K$ 21.00K$ -64.00K$ 22.00K
Currency in USD

Caladrius Biosciences Earnings and Revenue History

Caladrius Biosciences Debt to Assets

Caladrius Biosciences Cash Flow

Caladrius Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis